Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 18 citing Qureshi: A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects. (0.08 sec) 

{alpha}-Cells of the endocrine pancreas: 35 years of research but the enigma …

- endojournals.org
J Gromada, I Franklin, CB Wollheim - Endocrine reviews, 2007 - Endocrine Soc
Glucagon, a hormone secreted from the -cells of the endocrine pancreas, is critical for blood
glucose homeostasis. It is the major counterpart to insulin and is released during hypoglycemia
to induce hepatic glucose output. The control of glucagon secretion is multifactorial and ...
Cited by 61 - Related articles - BL Direct - All 4 versions

The role of {alpha}-cell dysregulation in fasting and postprandial hyperglycemia in …

- endojournals.org
BE Dunning, JE Gerich - Endocrine reviews, 2007 - Endocrine Soc
The hyperglycemic activity of pancreatic extracts was encountered some 80 yr ago during efforts
to optimize methods for the purification of insulin. The hyperglycemic substance was named
"glucagon," and it was subsequently determined that glucagon is a 29-amino acid peptide ...
Cited by 32 - Related articles - BL Direct - All 5 versions

Proglucagon-derived peptides: mechanisms of action and therapeutic potential

- physiology.org
EM Sinclair, DJ Drucker - Physiology, 2005 - Am Physiological Soc
The proglucagon-derived peptides (PGDPs) are encoded by a single mammalian proglucagon
gene. Tissue-specific posttranslational processing mediated by prohormone convertase
(PC) enzymes liberates these peptide hormones in a tissue-specific manner (FIGURE 1 ...
Cited by 30 - Related articles - All 4 versions

New hepatic targets for glycaemic control in diabetes


L Agius - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier
Type-2 diabetes is associated with impaired glucose clearance by the liver in the postprandial
state, and with elevated glucose production in the post-absorptive state. New targets within the
liver are currently being investigated for development of antihyperglycaemic drugs for ...
Cited by 17 - Related articles - All 17 versions

Glucagon receptor knockout mice are resistant to diet-induced obesity and …


SL Conarello, G Jiang, J Mu, Z Li, J Woods, E Zycband, … - Diabetologia, 2007 - Springer
Abstract Aims/hypothesis Under normal physiological conditions, glucagon signalling is important
in glucose homeostasis. Hyperglucagonaemia or altered insulin:glucagon ratio plays a role in
maintaining hyperglycaemia in subjects with type 2 diabetes. It has been reported that ...
Cited by 11 - Related articles - BL Direct - All 4 versions

Glucagon as a target for the treatment of type 2 diabetes


KW Sloop, MD Michael, JS Moyers - Expert Opin. Ther. Targets, 2005 - informahealthcare.com
Glucagon is the key counter-regulatory hormone that opposes the action of insulin. In states of
relative hypoglycaemia, glucagon acts to increase blood glucose by stimulating hepatic glycogen
breakdown and gluconeogenesis to achieve euglycaemia. Type 2 diabetes is ...
Cited by 12 - Related articles - BL Direct - All 4 versions

Physiology of the pancreatic {alpha}-cell and glucagon secretion: role in glucose …

- endocrinology-journals.org
I Quesada, E Tuduri, C Ripoll, A Nadal - Journal of Endocrinology, 2008 - Soc Endocrinology
The secretion of glucagon by pancreatic -cells plays a critical role in the regulation of
glycaemia. This hormone counteracts hypoglycaemia and opposes insulin actions by stimulating
hepatic glucose synthesis and mobilization, thereby increasing blood glucose ...
Cited by 8 - Related articles - All 3 versions

Discovery of novel, potent, and orally active spiro-urea human glucagon receptor …


DM Shen, F Zhang, EJ Brady, MR Candelore, Q … - Bioorganic & Medicinal …, 2005 - Elsevier
AM1 computer modeling of compound 1 with the three peripheral substituents truncated for ease
of computation showed conformers A and B to have very similar energies. 12 A quick visual inspection
revealed that a slightly lower energy conformer B was well-suited for the formation of a ...
Cited by 6 - Related articles - All 4 versions

A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose …

- aspetjournals.org
N Rivera, CA Everett-Grueter, DS Edgerton, T … - Journal of Pharmacology …, 2007 - ASPET
Elevated glucagon is associated with fasting hyperglycemia in type 2 diabetes. We assessed
the effects of the glucagon receptor antagonist (2R)-N-[4-({4-(1-cyclohexen-1-yl)[(3,5-dichloroanilino
)carbonyl]anilino}methyl)benzoyl]-2-hydroxy-b-alanine (NNC 25-0926) on hepatic ...
Cited by 3 - Related articles - All 5 versions

Targeting glucagon receptor signalling in treating metabolic syndrome and renal …


C Xiao… - Clinical science (London, England: 1979), 2007 - pubmedcentral.nih.gov
Pancreatic bi-hormones insulin and glucagon are the Yin and Yang in the regulation of glucose
metabolism and homoeostasis. Insulin is synthesized primarily by pancreatic β-cells and is released
in response to an increase in blood glucose levels (hyperglycaemia). By contrast, ...
Cited by 3 - Related articles - BL Direct - All 9 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google